2018 SHBC PANEL TOPICS
Panel 1: Identifying and exploring promising discoveries
Bringing together academics and successful entrepreneurs, this panel explores recent trends in starting a healthcare venture. Panelists will discuss their perspectives on topics such as leading indicators for successful start-ups, barriers to entry, and early financing. Learn about what it takes to go from idea / opportunity to start-up and the unique challenges entrepreneurs face in the healthcare industry.
Panel 2: Finding the right partners at the right time
Founders' ability to bring innovations to market is highly dependent on navigating a challenging healthcare environment, marked by evolving payment models and financing hurdles. As a result, collaboration across the spectrum of stakeholders – universities, providers, startups, established biopharma companies, VCs and funders – seems to be a fundamental driver of success now more than ever. Panelists will provide insight on how to spark effective partnerships and raise funding to materialize innovation. The participants, with experiences reflecting the diversity of the involved stakeholders, will explore recent trends and strategic considerations for effective partnership, including choosing timing, navigating options for funding, sourcing and evaluating opportunities, and executing the collaboration.
Panel 3: Launching Personalized Medicine – Gene and Cell Therapy and Next Generation Therapuetics
Treatments are no longer a one-size-fits all prescription. Because patient experience is becoming equally important to patient outcome, scientists are harnessing the power of an individual’s DNA to enter the new frontier of medicine with personalized care using cell and gene therapy. Given the discoveries made to date, companies are at a critical juncture in bringing personalized care to patients. With this backdrop, this panel will explore the key decisions and challenges inherent in scaling ground-breaking personalized treatments and therapies.
Panel 4: The Future of Innovation in Healthcare and Biopharma
Scientific and technological innovation continuously accelerate, rapidly transforming the Healthcare landscape. Prenatal diagnostic, personalized medicine, In Home care, are increasingly part of our reality. This panel explores the opportunities and risks of the expected breakthrough, and proposes a reflection on some critical challenges to face in the coming years. Virtually every aspect of our lives will soon become digital, including health. Access to patient data is becoming more convenient with the proliferation of connected devices and is driving hopes for earlier, more efficient, and targeted treatments. However, this convenience adds to the already high cost of care. In this context, balancing innovation, privacy, and sustainability will be key. The foreseen shift toward preventative, out of hospital care, will also reinforce the role of caregivers and patients themselves, more involved than ever in their healthcare pathways. To draw a comprehensive picture, this panel brings together leaders of the insurance, regulation, academia, industry, and patient advocacy world.
PRIOR Year SHBC PANEL Topics
Panel: Genomics and Personalized Medicine in Biotech and Medical Devices
10:30 - 11:30 AM, MPR
Domenick Bertelli, Moderator, Partner at Putnam Associates
Bhavesh Ashar, US Oncology Franchise Head at Sanofi Genzyme
Dr. Paul de Bakker, Senior Director, Computational Genomics at Vertex
Dr. Birgit Schoeberl, Head of Discovery-SVP at Merrimack Pharmaceuticals
Dr. Robert Green, Director of Genomes2People Research Program, Brigham and Women’s; Associate director for research at Partners personalized medicine
Panel: Patient Activation through Digital Consumer Health
2:00 - 3:00 PM, MPR
Ashlee Adams, Moderator, VP of Strategy & Partnerships at Rock Health
Dr. Rajni Aneja, Global head of digital at Novartis
Lesley Solomon, Executive Director of Brigham Innovation Hub at Brigham and Women's Hospital
Sukanya Soderland, Partner, Health and Life Sciences Division at Oliver Wyman
Adam Hanina, CEO at AiCure
Panel: Providers, Payers and Policy Makers Digitizing Population Health Management
3:15 - 4:15 PM, MPR
Noam Kirson, Moderator, Vice President at Analysis Group
Bill Kassler, Deputy Chief Health Officer & Lead Population Health Officer at IBM Watson Health
Holly Oh, Chief Medical Officer at Dimock Community Health Center
Caitlin Reiche, Director Performance Management at athenahealth
Thomas C. Hawkins, Senior Medical Director, Population Health and Analytics at Blue Cross Blue Shield of Massachusetts